Valeant 株 急落（する），激減（する） on short-販売人 scrutiny of pharmacy 関係
By Caroline Humer
NEW YORK, Oct 21 (Reuters) - 株 of Valeant 製薬のs International Inc 急落（する），激減（する）d as much as 30 パーセント after an 影響力のある short-販売人 （刑事）被告 the company of 詐欺, 説 it used its 関係 with specialty pharmacies to inflate 歳入.
The 報告（する）／憶測 by Citron 研究, a short-selling 会社／堅い run by Andrew Left, said Wednesday that Valeant's 以前 公表されていない 関係 is a 調印する of a cover-up. Valeant spokeswoman Laurie Little was not すぐに 利用できる for comment.
The Citron 研究 報告（する）／憶測 攻撃する，衝突する 株 hard すぐに after 10 a.m. EDT (1400 GMT) in New York 貿易（する）ing. The 株 were last 貿易（する）ing 負かす／撃墜する $41.62 at $105.12, 代表するing a major loss for 億万長者 法案 Ackman, who 持つ／拘留するs a 5.7-パーセント 火刑／賭ける in Valeant.
株 of some 重要な competitors, 含むing Allergan Inc , Endo International Plc and Mallinckrodt Plc also fell はっきりと.
Citron 申し立てられた／疑わしい that Valeant was using specialty pharmacies - 含む Philidor and R&O Pharmacy Inc - to create "phantom sales" of its 製品s or 押し進めるing more 製品 through 配当 channels than sales would 令状, and to 避ける scrutiny from auditors.
"Citron believes the whole thing is a 詐欺 to create invoices to deceive the auditors and 調書をとる／予約する 歳入," the 公式文書，認める said.
Valeant has been under 解雇する／砲火／射撃 for several weeks over its practice of raising 麻薬 prices sh arply once it acquires new 医薬s. Last week, it 公表する／暴露するd that it was under 調査 by 連邦の 検察官，検事s in New York and Massachusetts.
The 政府 requested （警察などへの）密告，告訴（状） on pricing and on programs that help 患者s cover their out-of-pocket expenses for Valeant's 麻薬s. Those 麻薬s are often 分配するd by specialty pharmacies.
On Monday, during a 会議／協議会 call with 投資家s, Valeant defended its pricing and 拒絶する／低下するd to comment on the 連邦の 調査s, 説 it was 協力するing with 当局.
But the company 公表する／暴露するd new （警察などへの）密告，告訴（状） about its 取引，協定ing with two pharmacies, which 分配する specialty 麻薬s to 患者s, 含むing that it had 購入（する）d an 選択 to acquire Philidor and was already 強固にする／合併する／制圧するing its results.
Len Yaffe, an 投資家 at StocDoc Partners, who is short on Valeant, said that he is not yet sure of what to make of Citron's （人命などを）奪う，主張するs. He said the notion that Valeant would need to 訴える手段／行楽地 to phantom sales to juice 歳入s 高くする，増すs 存在するing 普及した 関心s about the company's ability to produce growth in an ますます 敵意を持った pricing 環境.
Valeant's 在庫／株 took a 重要な 攻撃する，衝突する in late September in 返答 to 批評 from Democratic 大統領の 候補者 Hillary Clinton about rising 麻薬 prices and マスコミ 報告（する）／憶測s of its 特に 法外な price 増加するs.
独立した・無所属 Canadian 公正，普通株主権 研究 会社／堅い Veritas said it saw 重要な unquantifiable 危険s overhanging Valeant.
分析家 Dimitry Khmelnitsky sees Valeant at 危険 of losing its 'secret sauce' that made it a darling of many 投資家s 予定 to the pullback in its 株 price. Valeant has 伝統的に used its 高度に-valued 株 to 追求する accretive 取得／買収s and tack on 負債.
The selloff on Wednesday knocked off $15 billion in market capitalization from Valeant, which was valued as high as $90 billion in 早期に August. It has since lost more than half of its value. (報告（する）／憶測ing by Caroline Humer and David Gaffen; 付加 報告（する）／憶測ing by Carl O'Donnell, Euan Rocha and Ransdell Pierson; Editing by Jeffrey Benkoe and Nick Zieminski)
